The Venture Codex

Participated · Equity · Aug 2026

Switchboard Health operates an AI-driven platform for specialty care navigation and automated referral management. Through the acquisition of Livara Health, Switchboard will embed a virtual-first, value-based MSK program—one whose 2024 review showed participants reduced MSK spending by 43%—into its workflows. The company previously acquired AI personalized multispecialty care solution Conduce Health to integrate predictive models and advanced AI capabilities. Switchboard reports a 500% increase in patients routed through its platform over the past nine months and has raised $5 million in an oversubscribed round to fund expansion into care delivery. Leadership has stated the integration of Livara’s team, care model, and technology is expected to scale delivery of high-value MSK care within its navigation workflows.

Participated · Series B · Mar 2026

Greater Good Health partners with health plans, hospital systems, and provider groups to offer nurse practitioner–led primary care clinics and embedded clinical programs that lower total cost of care while improving quality and access. The company currently serves more than 200,000 patients through its clinics and integrated services platform, achieving 4-plus STAR quality scores, over 200 % growth in preventive-care engagement, reduced unnecessary acute admissions, and a Net Promoter Score above 90. Its first three clinics launched in Montana with Humana, and a fourth clinic opened in Idaho with Blue Cross of Idaho, highlighting the model’s scalability in underserved, aging markets. Based in El Segundo, California, Greater Good Health focuses on Medicare adults and addresses the national shortage of primary care physicians by elevating nurse practitioners to lead care teams. The organization functions as an extension of risk-bearing entities, supplying the infrastructure and staffing needed for longitudinal, value-based care management. With fresh capital, the company plans to deepen payer partnerships, strengthen its technology-enabled care platform, and expand into additional geographies.

Participated · Equity · Sep 2025

Harbor Health is a primary and specialty care clinic group and health insurance company that pairs care delivery with longitudinal coverage models. The company connects each member to a dedicated health team and customized care pathways, integrating primary care with specialty services. Harbor Health serves more than 50,000 people in Central Texas, reports a net promoter score of 90, and has grown from three clinics in 2022 to 11 clinics, plus two mobile clinics and an infusion center. It plans to expand its clinical footprint across Texas and add specialty service lines including rheumatology, dermatology, cardiology, endocrinology, and mental health. In November 2025 Harbor Health will offer fully insured individual and family plans on healthcare.gov while continuing to provide quotes for large employer plans in Central Texas. The company says its integrated care-and-coverage model can deliver 10–20% savings while improving outcomes. Harbor Health is an Austin, TX-based primary and specialty clinic group that delivers primary care and expanded specialty services for employers, providers and individual consumers. The team connects consumers to a dedicated health team and customized care pathways, emphasizing a personalized, relationship-driven approach. The company says this model helps consumers get healthier faster and reduces the emotional and financial burdens of the current healthcare system. Harbor Health plans to use new funding to accelerate growth in primary care services, broaden its specialty care offerings, and develop plan designs that support care journeys co-created by consumers and their clinicians. The company was founded by Dr. Clay Johnston, Eric Scott (from 8VC) and Tony Miller.

Participated · Seed · Jun 2025

ArcheHealth offers an AI-based platform that analyzes de-identified clinical, financial, and operational data to provide hospitals detailed, patient-level views of the true costs of care. The platform surfaces process inefficiencies and opportunities to reduce costs across labor, supplies, and drugs, enabling a shift from reactive to proactive performance management. ArcheHealth leverages deep process analysis, AI analytics, predictive modeling, and benchmarking without disrupting existing ERP, EHR, or other systems. The company is led by CEO Ralph Keiser, a healthcare IT veteran with prior leadership roles at EPSi, @Outcome, Cerner's PowerInsight, and Deloitte's ConvergeHEALTH. ArcheHealth will use the funding to scale operations and further develop its AI-based platform technology. The company positions itself to drive sustainable margin growth and operational excellence for health systems.

Participated · Equity · Feb 2025

BEKhealth, based in Research Triangle Park, NC, provides an AI-powered chart abstraction and patient-matching platform that extracts structured and unstructured data from electronic medical records (EMRs). The technology integrates EHR data to optimize population feasibility and rapidly identify clinically qualified participants for clinical research. Its platform supports organizations conducting clinical trials, observational research, and real-world evidence generation by improving protocol design and participant identification. The company announced customer growth in 2024 and now counts clients such as Avacare Clinical Research Network, Biopharma Informatics, Chemidox, Elixia Health, Javara, Om Research and others. BEKhealth raised $4M in funding and intends to use the proceeds to continue expanding its customer base and product offering. The company highlights its focus on expanding commercial adoption and enhancing its AI-driven capabilities to better serve research sponsors and sites. BEKHealth offers an AI-powered clinical research software platform that ingests and processes both structured and unstructured EMR data to drive feasibility assessments, site selection, precision patient matching, and care coordination. Its machine learning models combine more than 400 unique medical libraries and 70,000 research protocols with an interoperable clinical data model to power automated, daily identification of protocol-eligible patients. The platform is positioned to accelerate patient enrollment, cut timelines, and improve outcomes for sites and CROs while addressing cumbersome workflows and data access challenges. BEKHealth says its tools are increasingly in demand amid a more virtual healthcare environment and growing use of analytics in clinical research. The company is privately held, venture-backed, and based in Connecticut, and plans to use new funding to grow its team and expand availability and adoption of its platform.